Have patients been harmed by unsafe drug compounding? Partnership for Safe Medicines FDA Peptide Reclassification 2026: What It Means for Providers Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Orthopedic Use of BPC 157 Sports Med Review FDA moves toward easing restrictions on certain peptides BioPharma Dive